Predicting risk of post-treatment relapse in patients with inflammatory bowel disease based on intestinal microbiota
Inflammatory bowel disease (IBD) is a chronic inflammatory condition affecting the gastrointestinal tract, with its relapse presenting a significant clinical challenge. Dysbiosis of the gut microbiota is closely associated with IBD relapse.